174 related articles for article (PubMed ID: 12237336)
1. Unexpected anthracycline-mediated alterations in iron-regulatory protein-RNA-binding activity: the iron and copper complexes of anthracyclines decrease RNA-binding activity.
Kwok JC; Richardson DR
Mol Pharmacol; 2002 Oct; 62(4):888-900. PubMed ID: 12237336
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G
Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422
[TBL] [Abstract][Full Text] [Related]
3. Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway.
Kwok JC; Richardson DR
Mol Pharmacol; 2003 Apr; 63(4):849-61. PubMed ID: 12644586
[TBL] [Abstract][Full Text] [Related]
4. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium.
Minotti G; Recalcati S; Mordente A; Liberi G; Calafiore AM; Mancuso C; Preziosi P; Cairo G
FASEB J; 1998 May; 12(7):541-52. PubMed ID: 9576481
[TBL] [Abstract][Full Text] [Related]
5. Modulation of iron regulatory protein-1 by various metals.
Oshiro S; Nozawa K; Hori M; Zhang C; Hashimoto Y; Kitajima S; Kawamura K
Biochem Biophys Res Commun; 2002 Jan; 290(1):213-8. PubMed ID: 11779155
[TBL] [Abstract][Full Text] [Related]
6. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of J774A.1 macrophages by direct disassembly of the Fe-S cluster of cytoplasmic aconitase.
Cairo G; Ronchi R; Recalcati S; Campanella A; Minotti G
Biochemistry; 2002 Jun; 41(23):7435-42. PubMed ID: 12044177
[TBL] [Abstract][Full Text] [Related]
8. Expression and biochemical characterization of iron regulatory proteins 1 and 2 in Saccharomyces cerevisiae.
Phillips JD; Guo B; Yu Y; Brown FM; Leibold EA
Biochemistry; 1996 Dec; 35(49):15704-14. PubMed ID: 8961933
[TBL] [Abstract][Full Text] [Related]
9. Dietary iron intake rapidly influences iron regulatory proteins, ferritin subunits and mitochondrial aconitase in rat liver.
Chen OS; Blemings KP; Schalinske KL; Eisenstein RS
J Nutr; 1998 Mar; 128(3):525-35. PubMed ID: 9482759
[TBL] [Abstract][Full Text] [Related]
10. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
11. Dietary iron intake modulates the activity of iron regulatory proteins and the abundance of ferritin and mitochondrial aconitase in rat liver.
Chen OS; Schalinske KL; Eisenstein RS
J Nutr; 1997 Feb; 127(2):238-48. PubMed ID: 9039823
[TBL] [Abstract][Full Text] [Related]
12. Oxalomalate, a competitive inhibitor of aconitase, modulates the RNA-binding activity of iron-regulatory proteins.
Festa M; Colonna A; Pietropaolo C; Ruffo A
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):315-20. PubMed ID: 10816424
[TBL] [Abstract][Full Text] [Related]
13. Interactions between doxorubicin and the human iron regulatory system.
Brazzolotto X; Andriollo M; Guiraud P; Favier A; Moulis JM
Biochim Biophys Acta; 2003 Feb; 1593(2-3):209-18. PubMed ID: 12581865
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells.
Schalinske KL; Eisenstein RS
J Biol Chem; 1996 Mar; 271(12):7168-76. PubMed ID: 8636154
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
Piñero DJ; Hu J; Connor JR
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
[TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacology of the interaction of anthracyclines with iron.
Xu X; Persson HL; Richardson DR
Mol Pharmacol; 2005 Aug; 68(2):261-71. PubMed ID: 15883202
[TBL] [Abstract][Full Text] [Related]
17. IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice.
Corna G; Galy B; Hentze MW; Cairo G
J Mol Med (Berl); 2006 Jul; 84(7):551-60. PubMed ID: 16770644
[TBL] [Abstract][Full Text] [Related]
18. Increased IRP1 and IRP2 RNA binding activity accompanies a reduction of the labile iron pool in HFE-expressing cells.
Roy CN; Blemings KP; Deck KM; Davies PS; Anderson EL; Eisenstein RS; Enns CA
J Cell Physiol; 2002 Feb; 190(2):218-26. PubMed ID: 11807826
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of iron responsive element-binding capacity and aconitase function of iron regulatory protein-1 of skin cells by ultraviolet A.
Giordani A; Martin ME; Beaumont C; Santus R; Morlière P
Photochem Photobiol; 2000 Dec; 72(6):746-52. PubMed ID: 11140262
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool.
Piñero DJ; Hu J; Cook BM; Scaduto RC; Connor JR
Biochim Biophys Acta; 2000 Sep; 1497(3):279-88. PubMed ID: 10996652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
